Ingevity Co. (NYSE:NGVT) Shares Acquired by Leeward Investments LLC MA

Leeward Investments LLC MA grew its position in Ingevity Co. (NYSE:NGVT) by 8.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 189,347 shares of the company’s stock after buying an additional 13,984 shares during the quarter. Leeward Investments LLC MA owned 0.52% of Ingevity worth $7,716,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. First Horizon Advisors Inc. lifted its position in shares of Ingevity by 45.9% during the third quarter. First Horizon Advisors Inc. now owns 862 shares of the company’s stock worth $34,000 after purchasing an additional 271 shares in the last quarter. KBC Group NV lifted its position in shares of Ingevity by 50.8% during the third quarter. KBC Group NV now owns 1,574 shares of the company’s stock worth $61,000 after purchasing an additional 530 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Ingevity by 179.6% during the third quarter. Blue Trust Inc. now owns 2,505 shares of the company’s stock worth $98,000 after purchasing an additional 1,609 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Ingevity by 27.3% during the third quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company’s stock worth $151,000 after purchasing an additional 831 shares in the last quarter. Finally, Empowered Funds LLC acquired a new position in shares of Ingevity in the fourth quarter worth $187,000. 91.59% of the stock is owned by institutional investors and hedge funds.

Ingevity Trading Down 1.4 %

NYSE NGVT opened at $46.11 on Monday. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86. Ingevity Co. has a 52 week low of $30.90 and a 52 week high of $56.29. The stock has a market capitalization of $1.68 billion, a PE ratio of -3.89 and a beta of 1.64. The firm has a 50 day moving average of $43.33 and a two-hundred day moving average of $41.18.

Ingevity (NYSE:NGVT) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.66. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The company had revenue of $298.80 million for the quarter, compared to analysts’ expectations of $297.40 million. As a group, research analysts expect that Ingevity Co. will post 4.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

NGVT has been the subject of several research reports. StockNews.com upgraded shares of Ingevity from a “hold” rating to a “buy” rating in a research note on Thursday. BMO Capital Markets boosted their price target on shares of Ingevity from $61.00 to $62.00 and gave the stock a “market perform” rating in a research note on Thursday. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $54.67.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.